Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Graphical Abstract Similar content being viewed by others Background Idiopathic intracranial hypertension (IIH) is a debilitating condition characterized by raised intracranial pressure causing chronic headaches and papilledema with the risk of permanent visual loss, which most commonly occurs in young obese women [1]
Over time, many clients notice improved body composition, increased energy, and a more toned appearance
Its ability to enhance blood flow, support collagen organization, and modulate inflammation makes it biologically plausible as a healing aid
hsCRP reduction by dose: 5 mg tirzepatide: Mean difference of -20.3 compared to placebo (95% CI: -35.2 to -5.3) 10 mg tirzepatide: Mean difference of -33.9 compared to placebo (95% CI: -50.3 to -17.6) 15 mg tirzepatide: Mean difference of -32.9 compared to placebo (95% CI: -33.6 to -32.2) Notice something
Avoid exfoliants, retinoids, or harsh products 24 hours before treatment
How many units are needed
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
